The 5 Startups that take the next step in the Start4Health program
Pfizer's Acceleration Program, which focuses on Digital Health and its various industries, contributes to the development of new solutions and new technology products that can improve the provision of healthcare and the Health sector as a whole
Five dynamic, Greek Startups have moved on to the next phase of the Start4Health Program of Pfizer‘s Center for Digital Innovation (CDI). Both the five “finalists” and all participants from the first phase of the program left excellent impressions and promises for the future of the effort to develop innovative digital ideas and innovative technology solutions aimed at improving health services and patients’ lives.
Start4Health is an Accelerator that focuses on Digital Health and its various industries, looking for new technology products and services that can improve healthcare delivery, enhance and personalize the therapeutic process, provide intelligent data collection and analysis for remote monitoring and support, improve the speed and accuracy of diagnosis, and increase patient participation, their knowledge and awareness of Health.
With the completion of the first phase of the Program, the Open Call, the five proposals that stood out and passed to the next phase are:
Althexis: An innovative platform and technology that offers innovation in the way dermatological tests are conducted.
Cloudpharm: Cutting-edge technology that enhances research and development (R&D) of retargeting.
Collaborate Health Cloud: A complete solution that supports health providers and patients in the prevention and more effective management of chronic and / or rare diseases.
Docandu: A company providing innovative digital health services and patient-centered telemedicine.
eNiOS: Technology for the analysis of large biological data with application in precision medicine and drug research and development.
In the next phase, the Accelerator, through a six-week program, the five companies will further develop their proposals with the support of mentors and coaches from the technology and business ecosystem, including Pfizer executives.
The Program will conclude with the Demo Day, during which the advanced and mature proposals will be presented to a Jury, which will consist of distinguished personalities from the field of Technology, Innovation and Business. The Committee will select and award the two best proposals with cash prizes of 25 thousand euros and 10 thousand euros for the first and second winning teams, respectively.
In addition to cash prizes, teams through their participation will have the opportunity to optimize their business model, improve the value of their proposals, strengthen their position in the market and, possibly, secure a future partnership with Pfizer.
“For us at CDI, Start4Health is another tool to strengthen our links with the Greek technology and innovation ecosystem.The participation in the first phase of the program was large and of a very high level, justifying our trust in the ecosystem. And we are very happy that five such dynamic Startups, with innovative proposals, continue in the next phase. By offering through the program opportunities for collaboration between great talents and dynamic teams, we want to contribute to the coming to the fore of innovative proposals and solutions that could revolutionize the health industry, which is our constant goal and mission,” said Nico Gariboldi, Head of the CDI.
The Center for Digital Innovation (CDI) of Pfizer was founded in 2020 in Thessaloniki and is part of the Pfizer Digital global network.
CDI organizes Start4Health in collaboration with the non-profit organization SciCo and Found.ation.
